Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

FDA Approves Medtronic PLC (MDT) Claria MRI Quad CRT-D SureScan

The US Food and Drug Administration (FDA) has recently granted Medtronic PLC (NYSE:MDT) the approval for the Claria Magnetic Resonance Imaging (MRI) Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan for patients with heart failure conditions.

Claria MRI Quad CRT-D SureScan Approval

The device boasts EffectivCRT, an algorithm that automatically adjusts pacing rates to provide personalized therapy. It has been approved for scanning in 1.50 and 3 Tesla (T) MRI devices.

Most Advanced Countries in Medicine

everything possible/

The Claria MRI Quad CRT-D SureScan is the first approved device capable of automatically adjusting pacing to provide improved treatment for patients. Most heart failure patients receiving CRT have atrial fibrillation (AF), which can negatively affect patients’ response to the treatment. With EffectivCRT, the pacing is automatically adjusted in accordance to AF without affecting patients’ normal heart rate.

“With the Claria device, physicians are now able to verify the effectiveness of left ventricular pacing, which is especially beneficial for improving outcomes in patients with atrial fibrillation, who have been difficult to treat because this irregular and rapid heartbeat often interferes with the delivery of effective CRT,” reiterated Suneet Mittal, M.D., Arrhythmia Institute of the Valley Health System Director of Electrophysiology Laboratory.

Other interesting features of the device include the AdaptivCRT, an algorithm minimizing a patient’s risk of a 30-day heart failure readmission and AF risk; VectorExpress 2.0, an automated test reducing lead programming to two minutes; Attain Perfoma MRI SureScan Quadripolar Leads, which reduces phrenic nerve stimulation occurrence; SureScan MR-conditional labeling, which facilitates full-body scans without restrictions.

43rd Annual Symposium of Vascular and Endovascular Issues (VEITHsymposium) Presentation

On Tuesday, Medtronic PLC (NYSE:MDT) is to begin delivering presentations of clinical trials involving endovascular treatments among core and complex aortic patients at the 43rd VEITHsymposium, the largest vascular surgical medicine educational symposium in the world.

The company will present new and/or updated data from the ENGAGE Global Registry, ANCHOR Registry, PROTAGORAS clinical trial, and on the Valiant Captivia system. Presentations involving the Valiant Mona LSA, Valiant EVO thoracic stent graft system, Valiant TAAA stent graft system, and Valiant ascending stent graft system are also included.

Medtronic PLC (NYSE:MDT) lost 4.05% on Monday, closing at $78.75.

Follow Medtronic Inc (NYSE:MDT)
Trade (NYSE:MDT) Now!

Note: This article is written by Adam Russell and was originally published at Market Exclusive.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.